Intracameral triamcinolone acetonide after pediatric cataract surgery.
OBJECTIVE
To assess the use of preservative-free intracameral triamcinolone as an adjunct to topical steroidal agents after pediatric cataract surgery.


METHODS
Children's University Hospital, Dublin, Ireland.


METHODS
Retrospective case series.


METHODS
From the 2008 to 2009, intracameral preservative-free triamcinolone 4 mg/0.1 mL (Triesence) was used immediately after cataract surgery. Clinical indices of anterior segment inflammation were assessed at 1, 7, 14, 21 days and at 6 weeks postoperatively.


RESULTS
There were no complications secondary to triamcinolone use in 36 eyes of 26 children. In all but 1 case, intracameral triamcinolone was highly effective in controlling postoperative inflammation after pediatric cataract surgery, resulting in quiet eyes with few inflammatory signs (grade 0 to 1).


CONCLUSIONS
Intracameral triamcinolone provided a safe and useful adjunct to topical steroid drops after pediatric cataract surgery.
Cleary
Catherine A
CA
Doheny Eye Institute, University of Southern California, Los Angeles, California, USA.
Lanigan
Bernadette
B
O'Keeffe
Michael
M
D000287:Administration, Topical; D000293:Adolescent; D000867:Anterior Chamber / Q000187:drug effects*; D002387:Cataract Extraction; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D007223:Infant; D008297:Male; D011183:Postoperative Complications / Q000517:prevention & control; D011239:Prednisolone / Q000008:administration & dosage / Q000031:analogs & derivatives; D011310:Preservatives, Pharmaceutical; D012189:Retrospective Studies; D014222:Triamcinolone Acetonide / Q000008:administration & dosage*; D014606:Uveitis, Anterior / Q000517:prevention & control*
D005938:Glucocorticoids; D011310:Preservatives, Pharmaceutical; C009935:prednisolone acetate; D011239:Prednisolone; D014222:Triamcinolone Acetonide